Med-Tech Startups Survive SVB Collapse but Face New Concerns
While only time will tell how bad the ultimate damage turns out to be, it appears for now at least that the industry has dodged a bullet.
While only time will tell how bad the ultimate damage turns out to be, it appears for now at least that the industry has dodged a bullet.